BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

TherapeuticsMD, Inc. 

951 Broken Sound Parkway NW
Suite #320
Boca Raton  Florida  33487  U.S.A.
Phone: 561-961-1911 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Secondary Offering 3/21/2014 8:57:40 AM    More...
TherapeuticsMD, Inc.  (TXMD) To Present At The Cowen and Company 34th Annual Health Care Conference 2/26/2014 7:44:41 AM    More...
TherapeuticsMD, Inc.  (TXMD) To Host Conference Call And Live Audio Webcast To Disclose Financial Results For Quarter And Year Ended December 31, 2013 2/25/2014 7:52:00 AM    More...
TherapeuticsMD, Inc.  (TXMD) Reports Positive PK Study Results For Its Estradiol Vaginal Capsule Vagicap™ (TX 12-004-HR) For Treatment Of Vulvar Vaginal Atrophy (VVA) 1/28/2014 7:44:28 AM    More...
TherapeuticsMD, Inc.  (TXMD) Initiates Phase 3 Clinical Trial Of Its Progesterone Candidate (TX 12-002-HR) For Treatment Of Secondary Amenorrhea 1/24/2014 9:19:19 AM    More...
TherapeuticsMD, Inc.  (TXMD) Announces Milestone Achievement Of 50th Site For Phase 3 Clinical Trial Of TX 12-001HR To Treat Symptoms Of Menopause And Provide Endometrial Protection 1/6/2014 9:26:35 AM    More...
TherapeuticsMD, Inc.  (TXMD) Names Randall S. Stanicky To Board Of Directors 12/18/2013 6:36:04 AM    More...
TherapeuticsMD, Inc.  (TXMD) Receives Notice Of Allowance For Patent Covering Platform Technology Of Oral Combination Bioidentical 17ß-Estradiol And Progesterone 12/9/2013 10:17:22 AM    More...
TherapeuticsMD, Inc.  (TXMD) To Present At 25th Annual Piper Jaffray Healthcare Conference 11/22/2013 8:12:11 AM    More...
TherapeuticsMD, Inc.  (TXMD) Applauds Congressional Leadership On Passage Of Drug Quality And Security Act 11/19/2013 8:35:47 AM    More...
123

//-->